ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of CYP3A5 Phenotype on Early Time in Therapeutic Range among Pediatric Renal and Heart Transplant Recipients

A. Leino, A. Pasternak

University of Michigan, Ann Arbor, MI

Meeting: 2020 American Transplant Congress

Abstract number: 604

Keywords: Calcineurin, Gene polymorphism, Pediatric

Session Information

Session Name: All Organs: Pharmacogenomics / Pharmacokinetics

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:27pm-3:39pm

Location: Virtual

*Purpose: Tacrolimus time in therapeutic range (TTR) as a measure of intra-patient variability has been associated with poor long-term outcomes. Multiple factors may contribute to TTR but few have been evaluated. The purpose of this study was to investigate the impact of CYP3A5 phenotype on TTR early post-transplant in pediatric patients.

*Methods: This was a retrospective analysis of all pediatric patients who underwent renal or heart transplant from 6/1/14 to 12/31/18 and were initiated on tacrolimus with whole blood or buffy coat samples available for secondary use. Samples were genotyped for CYP3A5*3, CYP3A5*6, and CYP3A5*7 and categorized as CYP3A5 expressers (CYP3A5*1) or CYP3A5 non-expressers. TTR was calculated for the first 90 days post-transplant using the Rosendaal linear interpolation method. Target tacrolimus levels were 8-12ng/mL in kidney recipients and 10-15 ng/mL in heart recipients. Per protocol, initial dose of tacrolimus was 0.1 mg/kg twice daily. The primary outcome compared 90-day TTR between CYP3A5 expressers and non-expressers using simple and multiple linear regression.

*Results: A total of 85 pediatric transplant patients were analyzed; 37 heart recipients and 48 kidney recipients. Nineteen patients were CYP3A5 expressers and 66 were CYP3A5 non-expressers. TTR in the first 90 days post-transplant was significantly higher among non-expressers (57.95% vs 47.29%, p=0.026; figure 1). The difference remained significant when controlling for organ type and initial dose (p= 0.029).As expected, CYP3A5 expressers required a higher dose at all evaluated timepoints (table 1). However, there was no difference in the time to the first stable, therapeutic trough defined as ≥2 sequential troughs within target (18.2 days vs 21.2 days, p=0.057; figure 2). There was also no difference when controlling for organ type and initial dose (p=0.346). A post hoc analysis of 30-day TTR also found no difference by CYP3A5 phenotype (49.1% vs 46.75%, p=0.67).

*Conclusions: CYP3A5 phenotype is associated with TTR early post-transplant beyond the known increase in time to first therapeutic level. Future work should further explore the benefit of genotype directed dosing on TTR.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Leino A, Pasternak A. Impact of CYP3A5 Phenotype on Early Time in Therapeutic Range among Pediatric Renal and Heart Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-cyp3a5-phenotype-on-early-time-in-therapeutic-range-among-pediatric-renal-and-heart-transplant-recipients/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences